Project Grant R01AI180128
Award Date
8/15/24
Completion Date
7/31/29
Dollars Obligated
$300K
Funding Federal Agency
Office of the Director
Awarding Federal Agency
National Institute of Allergy and Infectious Diseases
Federal Grant Program
93.310
Assistance Type
Project Grant
Place of Performance
New York, NY 10016, USA
Similar Awards
The National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded a Project Grant of $558,045 to Beth Israel Deaconess Medical Center, Inc. (Bidmc) on May 7, 2025. The grant will fund research to investigate how the enzyme protein phosphatase 2A (PP2A) controls the development and function of regulatory T cells by acting on metabolic enzymes involved in glycolysis and the pentose phosphate pathway. The research...
This Project Grant award, provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports research to identify the transcriptional regulators that control human natural killer (NK) cell function during viral infections such as human cytomegalovirus (HCMV). The $666,567 award, which runs from May 2025 to April 2030, will fund investigations into the mechanisms by which the transcription factor MEF2C...
This federal Project Grant award, funded by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training Program (CFDA 93.859), supports research to study the structure, function, and regulation of ATP-sensitive potassium (KATP) channels. The award of $385,191 to The Trustees of Trinity College in Hartford, Connecticut will be utilized over a 3-year period from September 1, 2024 to August 31, 2027. The primary focus of the research is to...
The New York University (NYU) School of Medicine was awarded a $1,525,500 Project Grant by the National Institutes of Health (NIH) Office of the Director under the Trans-NIH Research Support program (CFDA 93.310). The grant funding, which runs from September 1, 2024 to August 31, 2027, supports the development of new technologies to address two major bottlenecks in the chimeric antigen receptor (CAR) T cell therapy development process: identifying tumor-specific antigens and engineering...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) provides $392,024 to conduct research on the molecular mechanisms of the vacuolar ATPase (V-ATPase) enzyme and its role in cellular signaling pathways. The research program aims to: 1) delineate the complete reaction cycle of the V-ATPase using cryo-electron microscopy and biochemical assays; 2) elucidate the molecular mechanism by which the...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $150,921 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the University of Virginia. The purpose of this 3-year grant, with a period of performance from November 30, 2024 to April 30, 2027, is to investigate how T cell signaling is regulated by the interplay between membrane lipid rafts and protein condensates. The research aims to characterize the biophysical properties of...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to New York University School of Medicine. The $246,623 grant, with a project period from November 20, 2024 to October 31, 2026, will support research to investigate the molecular control of tolerogenic dendritic cell function. The project aims to pinpoint the specific dendritic cell subsets responsible for maintaining immune...
This $1,559,700 Project Grant award from the National Institutes of Health (NIH) Office of the Director under the Trans-NIH Research Support program (CFDA 93.310) funds research by the Benaroya Research Institute at Virginia Mason (BRI) to investigate how genetic and epigenetic factors influence T cell function in autoimmune diseases. The key objectives are to: 1) use CRISPR-interference screening to identify regulatory regions that impact T cell proliferation and migration, 2) apply single-cell...
This $239,348 federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), will support research to investigate a newly identified population of CD1a-restricted T cells that respond to the lipid antigen phosphatidylglycerol (PG). The researchers at The Trustees of Columbia University in the City of New York will examine the conditions under which mitochondrial PG becomes visible to...
This $189,540 Project Grant was awarded on April 18, 2025 by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The grant supports research to determine how the fat-binding protein Apolipoprotein E (APOE) regulates the function of lymph node stromal cells and impacts T cell activation and lipid metabolism. The research aims to define the role of APOE in lymph node stromal cells, reveal mechanisms driving...